Background Clinicians' bias related to patients' race and substance use history play a role in
pain management. However, patients' or clinicians' understandings about discriminatory …

Purpose This study examined perceived substance use, opioid knowledge, and barriers to
Black people accessing treatment for substance and opioid use disorder (SUD/OUD) …

Background Medical hospitalizations for people with opioid use disorder (OUD) frequently
result in patient-directed discharges (PDD), often due to untreated pain and withdrawal …

Abstract Disparities between Black and White Americans in health care coverage and health
outcomes are pervasive in the United States. In this paper, we describe the evolution of the …

For more than a decade, drug overdose deaths have been the leading cause of injury death
in the US. During the COVID-19 pandemic and its related stressors and disruptions in …

Deaths due to synthetic opioids have increased at higher rates for Blacks and Hispanics
than for Whites in the last decade. Meanwhile, Blacks and Hispanics experience lower …

Background: Little is known regarding the extent to which substance use disorder (SUD)
treatment facilities adopt comprehensive services to meet patients' medical and social …

The older adult population in the United States (US) is becoming more racially and
ethnically diverse, whereas most practicing neuropsychologists are white. Psychologists …

Background: Buprenorphine/naloxone (Suboxone) is widely considered the first-line
treatment for opioid use disorder (OUD), which causes significant morbidity and mortality in …

In 2017, the opioid epidemic was declared a public health emergency. In the past 2
decades, opioids had been implicated in 500,000 deaths in the United States, with more …